Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with locally advanced, inoperable, or metastatic stomach cancer or gastroesophageal junction cancer (where the stomach meets the food pipe) confirmed by laboratory testing.
- People who are 18 years of age or older at the time of starting the study drug and signing the consent form, and who are able to give informed consent.
- People whose cancer tests show HER2-positive status (a specific protein level measured by laboratory tests, recorded as IHC 3+, or IHC 2+ with a second confirming test called ISH+).
- People who have already received prior cancer treatment as recommended under national medicine authority guidelines or as decided by their treating doctor.
- People for whom a doctor has decided to start the study drug (T-DXd) before joining the trial, or who started the study drug no more than 21 days before enrolling, provided a signed and dated consent form can be obtained.
Who may not be able to join:
- People who are pregnant or currently breastfeeding.
- People who are currently taking part in, or have previously taken part in, another interventional clinical trial that is still blinded (meaning the results or treatment assignment have not yet been revealed).
- People who are known to have a serious allergy or sensitivity to the study drug or any of its ingredients.
- People whom the trial investigator considers unfit to participate in the study for any reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Project Manager, Daiichi Sankyo Co., Ltd.
Phone: 908-992-6400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Real-world Time to Treatment Failure (rwTTF)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.